153 related articles for article (PubMed ID: 37223026)
1. Recurrence and mortality rate in an Italian multi-center case series of parathyroid atypical adenomas and carcinomas.
Barale M; Nervo A; Craparo A; Pusterla A; Retta F; Maiorino F; Castellano E; Piovesan A; Gianotti L; Borretta G; Procopio M; Arvat E
Front Endocrinol (Lausanne); 2023; 14():1158474. PubMed ID: 37223026
[TBL] [Abstract][Full Text] [Related]
2. A nationwide study on parathyroid carcinoma.
Ryhänen EM; Leijon H; Metso S; Eloranta E; Korsoff P; Ahtiainen P; Kekäläinen P; Tamminen M; Ristamäki R; Knutar O; Löyttyniemi E; Niskanen L; Väisänen M; Heiskanen I; Välimäki MJ; Laakso M; Haglund C; Arola J; Schalin-Jäntti C
Acta Oncol; 2017 Jul; 56(7):991-1003. PubMed ID: 28362521
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.
Ozolins A; Narbuts Z; Vanags A; Simtniece Z; Visnevska Z; Akca A; Wirowski D; Gardovskis J; Strumfa I; Goretzki PE
Langenbecks Arch Surg; 2016 Nov; 401(7):943-951. PubMed ID: 26658808
[TBL] [Abstract][Full Text] [Related]
4. Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases.
Erickson LA; Jin L; Papotti M; Lloyd RV
Am J Surg Pathol; 2002 Mar; 26(3):344-9. PubMed ID: 11859206
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort.
Chen Y; Song A; Nie M; Jiang Y; Li M; Xia W; Wang O; Xing X
Front Endocrinol (Lausanne); 2023; 14():1027598. PubMed ID: 36777354
[TBL] [Abstract][Full Text] [Related]
6. Modern experience with aggressive parathyroid tumors in a high-volume New England referral center.
Quinn CE; Healy J; Lebastchi AH; Brown TC; Stein JE; Prasad ML; Callender GG; Carling T; Udelsman R
J Am Coll Surg; 2015 Jun; 220(6):1054-62. PubMed ID: 25488353
[TBL] [Abstract][Full Text] [Related]
7. Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.
Sumislawski P; Huckhagel T; Krajewski KL; Aberle J; Saeger W; Flitsch J; Rotermund R
Sci Rep; 2023 Feb; 13(1):2468. PubMed ID: 36774403
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis?
Fernandez-Ranvier GG; Khanafshar E; Jensen K; Zarnegar R; Lee J; Kebebew E; Duh QY; Clark OH
Cancer; 2007 Jul; 110(2):255-64. PubMed ID: 17559137
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Expression of E-Cadherin in Atypical Parathyroid Adenoma.
Schneider R; Bartsch-Herzog S; Ramaswamy A; Bartsch DK; Karakas E
World J Surg; 2015 Oct; 39(10):2477-83. PubMed ID: 26154578
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases.
Bergero N; De Pompa R; Sacerdote C; Gasparri G; Volante M; Bussolati G; Papotti M
Hum Pathol; 2005 Aug; 36(8):908-14. PubMed ID: 16112008
[TBL] [Abstract][Full Text] [Related]
11. Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer.
Christakis I; Bussaidy N; Clarke C; Kwatampora LJ; Warneke CL; Silva AM; Williams MD; Grubbs EG; Lee JE; Perrier ND
Ann Surg Oncol; 2016 Sep; 23(9):2889-97. PubMed ID: 27160525
[TBL] [Abstract][Full Text] [Related]
12. Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer.
Truran PP; Johnson SJ; Bliss RD; Lennard TW; Aspinall SR
World J Surg; 2014 Nov; 38(11):2845-54. PubMed ID: 25002250
[TBL] [Abstract][Full Text] [Related]
13. Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms.
Silva-Figueroa AM; Bassett R; Christakis I; Moreno P; Clarke CN; Busaidy NL; Grubbs EG; Lee JE; Perrier ND; Williams MD
Endocr Pathol; 2019 Dec; 30(4):285-296. PubMed ID: 31734935
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis.
Stojadinovic A; Hoos A; Nissan A; Dudas ME; Cordon-Cardo C; Shaha AR; Brennan MF; Singh B; Ghossein RA
Hum Pathol; 2003 Jan; 34(1):54-64. PubMed ID: 12605367
[TBL] [Abstract][Full Text] [Related]
15. Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma-A Rare, Highly Malignant Subtype.
Yu Y; Wang Y; Wu Q; Zhao X; Liu D; Zhao Y; Li Y; Wang G; Xu J; Chen J; Zhang N; Tian X
Front Endocrinol (Lausanne); 2021; 12():793718. PubMed ID: 34975762
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid carcinoma versus parathyroid adenoma in patients with profound hypercalcemia.
Levin KE; Galante M; Clark OH
Surgery; 1987 Jun; 101(6):649-60. PubMed ID: 3589961
[TBL] [Abstract][Full Text] [Related]
17. Preoperative diagnosis and prognosis in 40 Parathyroid Carcinoma Patients.
Xue S; Chen H; Lv C; Shen X; Ding J; Liu J; Chen X
Clin Endocrinol (Oxf); 2016 Jul; 85(1):29-36. PubMed ID: 26939543
[TBL] [Abstract][Full Text] [Related]
18. Indian primary hyperparathyroidism patients with parathyroid carcinoma do not differ in clinicoinvestigative characteristics from those with benign parathyroid pathology.
Agarwal G; Prasad KK; Kar DK; Krishnani N; Pandey R; Mishra SK
World J Surg; 2006 May; 30(5):732-42. PubMed ID: 16680588
[TBL] [Abstract][Full Text] [Related]
19. Do Patients With Atypical Parathyroid Adenoma Need Close Follow-up?
Saponaro F; Pardi E; Mazoni L; Borsari S; Torregrossa L; Apicella M; Frustaci G; Materazzi G; Miccoli P; Basolo F; Marcocci C; Cetani F
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4565-e4579. PubMed ID: 34157106
[TBL] [Abstract][Full Text] [Related]
20. [Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience].
Pelizzo MR; Piotto A; Bergamasco A; Rubello D; Casara D
Minerva Endocrinol; 2001 Mar; 26(1):23-9. PubMed ID: 11323564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
